1701 - 1710 of 6420 Results
Title
Year
-
OPENTitle: Mental health disparities and the role of perceived discrimination among Latinx individuals living with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105867End Page: 105867Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105867Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105867Citation Count: 4
-
OPENTitle: Interaction of PINK1 with nucleotides and kinetinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adj7408Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adj7408?download=trueCitation Count: 5
-
OPENTitle: An individualized tractography pipeline for the nucleus basalis of Meynert lateral tractJournal Name: Imaging NeurosciencePublisher: MIT PressVol: 2Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/imag_a_00067Best OA location URL: https://direct.mit.edu/imag/article-pdf/doi/10.1162/imag_a_00067/2200468/imag_a_00067.pdfCitation Count: 0
- Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study2023OPENTitle: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control studyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 1Start Page: fcad346End Page: fcad346Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad346Best OA location URL: https://doi.org/10.1093/braincomms/fcad346Citation Count: 5
-
OPENTitle: Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 113End Page: 122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29251Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851979Citation Count: 13
- Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)2021OPENTitle: Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.96.15_supplement.4286Citation Count: 3
-
OPENTitle: Gut mucosal cells transfer α-synuclein to the vagus nerveJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 8Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.172192Best OA location URL: https://doi.org/10.1172/jci.insight.172192Citation Count: 22
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://doi.org/10.1126/sciadv.adi8716Citation Count: 106
- Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B2023OPENTitle: Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55BJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 50Start Page: eadj1205End Page: eadj1205Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adj1205Best OA location URL: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/Lipofectamine_RNAiMAX_Reag_protocol.pdfCitation Count: 25
-
OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://doi.org/10.1126/sciadv.adk6191Citation Count: 27